Nevro to Participate in Wells Fargo 2022 MedTech R&D Spotlight Call Series
REDWOOD CITY, Calif., Feb. 18, 2022 /PRNewswire/ — Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic pain, today announced that D. Keith Grossman, Nevro’s Chairman, CEO and President, Rod…
Comments Off on Nevro to Participate in Wells Fargo 2022 MedTech R&D Spotlight Call Series